DocWire News Editors

DocwireNews

Diagnosed type 2 diabetes under the age of 40 is associated with an increased risk for death from <a href="https://www.docwirenews.com/docwire-pick/future-of-medicine-picks/ai-diagnosing-cardiovascular-disease-with-accuracy-equal-to-traditional-means/">cardiovascular disease</a>, new study results <a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.037885">published</a> in Circulation suggest.&ldquo;Our study shows the differences in excess diabetes risk are tied to how old the person is when they are diagnosed with type 2 diabetes,&rdquo; said Naveed Sattar, MD, PhD, lead author and professor of Metabolic Medicine at the University of Glasgow in the United Kingdom, in a press <a href="https://newsroom.heart.org/news/people-under-40-diagnosed-with-type-2-diabetes-face-excess-risk-of-cardiovascular-disease-death?preview=070b">release</a>.The researchers used data from the Swedish National Diabetes Registry. The study population included 318,083 patients with type 2 diabetes and about 1,575,108 matched control patients. The researchers followed deaths from heart disease from the years 1998 to 2014. They used Cox proportional hazards models for those without prior cardiovascular disease, repeating the process for the full study cohort. The study outcomes of interest included total mortality, cardiovascular mortality, noncardiovascular mortality, coronary heart disease, acute myocardial infarction, stroke, heart failure, and atrial fibrillation. There was a median follow-up period of 5.63 years.<h2>Attenuated Effect with Age</h2>According to the study results, patients with a diagnosis of type 2 diabetes before age 40 had the highest excess risk for most study outcomes compared to the controls (95% confidence intervals for all). This included for mortality (adjusted HR=2.05; 1.81 to 2.33), cardiovascular-related mortality (1.95; 1.68 to 2.25) , non-cardiovascular-related morality (1.95; &nbsp;1.68 to 2.25), heart failure (4.77; 3.86 to 5.89), and coronary heart disease (4.33; 3.82 to 4.91). The risk was attenuated as the decade in which the diagnosis was delivered increased. A diagnosis of type 2 diabetes beyond 80 years of age was essentially equivalent of that seen in controls.&ldquo;This suggests we need to be more aggressive in controlling risk factors in younger type 2 diabetes populations and especially in women,&rdquo; Sattar said. &ldquo;And, far less effort and resources could be spent screening people 80 and older for type 2 diabetes unless symptoms are present. Furthermore, our work could also be used to encourage middle-aged people at elevated diabetes risk to adopt <a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/eat-keep-heart-healthy/">lifestyle changes</a> to delay their diabetes by several years.&rdquo;According to the press release, this study was the first &ldquo;to compare the excess risks of dying from or developing cardiovascular disease in people diagnosed with type 2 diabetes and to adjust the risk for such outcomes given how long a person has had diabetes.&rdquo;<a href="https://twitter.com/UofGMVLS/statuses/1115263053757648899">https://twitter.com/UofGMVLS/statuses/1115263053757648899</a><a href="https://twitter.com/NavidMahootiMD/statuses/1115240728853123072">https://twitter.com/NavidMahootiMD/statuses/1115240728853123072</a>

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Diagnosed Type 2 Diabetes Before Age 40 Linked With Increased Mortality

Cardiology

Diagnosed type 2 diabetes under the age of 40 is associated with an increased risk for death from cardiovascular disease, new study results published in Circulation suggest. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe